JUNIPER-NETWORKS
15.3.2022 13:49:04 CET | Business Wire | Press release
Juniper Networks , (NYSE: JNPR), a leader in secure, AI-driven networks, today announced that Raiffeisen Informatik (R-IT), a provider of comprehensive IT-services for financial service and insurance providers, has deployed Juniper Apstra data center solutions to modernize and automate its network infrastructure to provide exceptional services for its customers.
R-IT works consistently and emphatically to provide high-quality services and fail-safe infrastructures to its customers 24/7. R-IT’s long standing customers rely on the provider’s consistent and innovative solutions that significantly increase their flexibility as well as R-IT’s added value, from lending business and receivables management through securities settlement, to data management and digitalized accounting.
Juniper Apstra, the company’s data center solution for automation, will simplify planning, design and operations for R-IT’s network teams, reducing configuration errors for a more predictable data center network while maximizing both reliability and speed to create a better user experience.
News Highlights:
- R-IT can simplify and automate its operations from design to deployment (Day 0 and 1) through everyday operations and assurance with the turnkey Apstra System.
- Apstra usesroot-cause analysis to reduce the duration of network issues and shorten maintenance time with maintenance-mode capabilities. With Apstra, R-IT can dramatically reduce the time needed to deliver new network services, achieving faster time to deployment and time to resolution.
- With automated, flexible and simplified operations, R-IT can push out new application updates and services with minimal downtime for smooth, consistent user experiences.
- By automating the network lifecycle, IT resources can be used more efficiently, freeing up the company’s talented IT staff for strategic work. Pressure on hiring infrastructure and operations staff is expected to be relieved.
- With its open, flexible architecture, Apstra enables R-IT to deploy and operate multivendor networks with the ease and simplicity of a single-vendor network.
- In R-IT’s data centers, Juniper QFX Series Switches provide a flexible network fabric with industry-leading throughput and scalability, an extensive routing stack, the open programmability of the Junos® OS and a broad set of EVPN-VXLAN and IP fabric capabilities.
Supporting quotes:
“Our deep industry knowledge and strong foundation help ensure that our customers receive the best IT service at the highest levels of security, performance and availability, so they can concentrate on their core processes. Juniper Apstra provides an automated network platform that allows us to serve our customers with greater business agility.”
- Michael Linhart, CEO, Raiffeisen Informatik
“Financial institutions are looking for operational services that are reliable, resilient and agile. R-IT is providing critical services to its customers 24/7, and Juniper supports that with our objective to fully automate changes and assure continuous operation. With intent-based networking automation to help modernize and automate R-IT’s complete data center, Apstra increased reliability without more headcounts.”
- Mike Bushong, Vice President, Data Center Product Management, Juniper Networks
Additional resources:
- Success Story: R-IT
- Follow Juniper Networks online: Facebook | Twitter | LinkedIn
- Juniper Blogs and Community: J-Net
About Juniper Networks
Juniper Networks is dedicated to dramatically simplifying network operations and driving superior experiences for end users. Our solutions deliver industry-leading insight, automation, security and AI to drive real business results. We believe that powering connections will bring us closer together while empowering us all to solve the world’s greatest challenges of well-being, sustainability and equality. Additional information can be found at Juniper Networks (www.juniper.net ) or connect with Juniper on Twitter , LinkedIn and Facebook .
Juniper Networks, the Juniper Networks logo, Juniper, Junos, and other trademarks listed here are registered trademarks of Juniper Networks, Inc. and/or its affiliates in the United States and other countries. Other names may be trademarks of their respective owners.
category-enterprise
View source version on businesswire.com: https://www.businesswire.com/news/home/20220315005126/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom